J. Biol. Chem., Vol. 265, Issue 23, 13484-13489, Aug, 1990

The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen

MC Naski, JW Fenton 2d, JM Maraganore, ST Olson and JA Shafer
Department of Biological Chemistry, University of Michigan, Ann Arbor 48109.

Hirudin, a potent 65-residue polypeptide inhibitor of alpha-thrombin found in the saliva of the leech Hirudo medicinalis, and fragments thereof are potentially useful as antithrombotic agents. Hirugen, the synthetic N-acetylated COOH-terminal dodecapeptide (Ac-Asn-Gly-Asp-Phe- Glu-Glu-Ile-Pro-Glu-Glu-Tyr(SO3)-Leu) of hirudin was shown in the present study to behave as a pure competitive inhibitor (Ki = 0.54 microM) of human alpha-thrombin-catalyzed release of fibrinopeptide A from human fibrinogen. In contrast to this inhibitory activity, hirugen slightly enhanced (increased kcat/Km 1.6-fold) alpha-thrombin-catalyzed hydrolysis of the fluorogenic tripeptide substrate N-p-Tosyl-Gly-Pro- Arg-7-amino-4-methylcoumarin. These observations indicate that hirugen binds to alpha-thrombin at an exosite distinct from the active site, and that interaction with this exosite is a major determinant of the competence of alpha-thrombin to bind fibrinogen. Consistent with this view, hirugen blocked binding of fibrin II to alpha-thrombin. Studies of the effect of hirugen on the rate of inactivation of alpha-thrombin by antithrombin III (AT), the major plasma inhibitor of alpha-thrombin, indicated that binding of hirugen to alpha-thrombin results in less than a 2.5-fold decrease in the rate of inactivation of alpha-thrombin by AT, both in the absence and presence of heparin. This behavior is distinct from that of active site-directed competitive inhibitors of alpha-thrombin which bind to alpha-thrombin and block both conversion of fibrinogen to fibrin and inactivation of alpha-thrombin by AT. Hirugen, an exosite-directed competitive inhibitor, blocks the interaction of alpha-thrombin with fibrinogen while leaving alpha- thrombin competent to react with AT. Thus, unlike active site-directed competitive inhibitors, hirugen should act in concert with AT and heparin to reduce the amount of fibrinogen that is processed during the lifetime of alpha-thrombin in plasma.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Y. Koh, M. Kazimirova, A. Trimnell, P. Takac, M. Labuda, P. A. Nuttall, and R. M. Kini Variegin, a Novel Fast and Tight Binding Thrombin Inhibitor from the Tropical Bont Tick J. Biol. Chem., October 5, 2007; 282(40): 29101 - 29113. [Abstract] [Full Text] [PDF]

				P. Panizzi, R. Friedrich, P. Fuentes-Prior, H. K. Kroh, J. Briggs, G. Tans, W. Bode, and P. E. Bock Novel Fluorescent Prothrombin Analogs as Probes of Staphylocoagulase-Prothrombin Interactions J. Biol. Chem., January 13, 2006; 281(2): 1169 - 1178. [Abstract] [Full Text] [PDF]

				K. Nogami, Q. Zhou, T. Myles, L. L. K. Leung, H. Wakabayashi, and P. J. Fay Exosite-interactive Regions in the A1 and A2 Domains of Factor VIII Facilitate Thrombin-catalyzed Cleavage of Heavy Chain J. Biol. Chem., May 6, 2005; 280(18): 18476 - 18487. [Abstract] [Full Text] [PDF]

				P. J. Anderson, A. Nesset, and P. E. Bock Effects of Activation Peptide Bond Cleavage and Fragment 2 Interactions on the Pathway of Exosite I Expression during Activation of Human Prethrombin 1 to Thrombin J. Biol. Chem., November 7, 2003; 278(45): 44482 - 44488. [Abstract] [Full Text] [PDF]

				I. M. Verhamme, S. T. Olson, D. M. Tollefsen, and P. E. Bock Binding of Exosite Ligands to Human Thrombin. RE-EVALUATION OF ALLOSTERIC LINKAGE BETWEEN THROMBIN EXOSITES I AND II J. Biol. Chem., February 22, 2002; 277(9): 6788 - 6798. [Abstract] [Full Text] [PDF]

				R. Q. Monteiro, P. E. Bock, M. L. Bianconi, and R. B. Zingali Characterization of bothrojaracin interaction with human prothrombin Protein Sci., September 1, 2001; 10(9): 1897 - 1904. [Abstract] [Full Text] [PDF]

				S. W. Hall, M. Nagashima, L. Zhao, J. Morser, and L. L. K. Leung Thrombin Interacts with Thrombomodulin, Protein C, and Thrombin-activatable Fibrinolysis Inhibitor via Specific and Distinct Domains J. Biol. Chem., September 3, 1999; 274(36): 25510 - 25516. [Abstract] [Full Text] [PDF]

				K. R. Dharmawardana, S. T. Olson, and P. E. Bock Role of Regulatory Exosite I in Binding of Thrombin to Human Factor V, Factor Va, Factor Va Subunits, and Activation Fragments J. Biol. Chem., June 25, 1999; 274(26): 18635 - 18643. [Abstract] [Full Text] [PDF]

				M.-T. Lai, E. Di Cera, and J. A. Shafer Kinetic Pathway for the Slow to Fast Transition of Thrombin. EVIDENCE OF LINKED LIGAND BINDING AT STRUCTURALLY DISTINCT DOMAINS J. Biol. Chem., November 28, 1997; 272(48): 30275 - 30282. [Abstract] [Full Text] [PDF]

				J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz Evidence for Allosteric Linkage between Exosites 1 and 2 of Thrombin J. Biol. Chem., October 10, 1997; 272(41): 25493 - 25499. [Abstract] [Full Text] [PDF]

				P. E. Bock, S. T. Olson, and I. Bjork Inactivation of Thrombin by Antithrombin Is Accompanied by Inactivation of Regulatory Exosite I J. Biol. Chem., August 8, 1997; 272(32): 19837 - 19845. [Abstract] [Full Text] [PDF]

				P. J. Hogg, C. M. Jackson, J. K. Labanowski, and P. E. Bock Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen J. Biol. Chem., October 18, 1996; 271(42): 26088 - 26095. [Abstract] [Full Text] [PDF]

				D. A. Meh, K. R. Siebenlist, and M. W. Mosesson Identification and Characterization of the Thrombin Binding Sites on Fibrin J. Biol. Chem., September 20, 1996; 271(38): 23121 - 23125. [Abstract] [Full Text] [PDF]

				C. T. Esmon and P. Lollar Involvement of Thrombin Anion-binding Exosites 1and 2in the Activation of Factor V and Factor VIII J. Biol. Chem., June 7, 1996; 271(23): 13882 - 13887. [Abstract] [Full Text] [PDF]

				P. J. Anderson, A. Nesset, K. R. Dharmawardana, and P. E. Bock Characterization of Proexosite I on Prothrombin J. Biol. Chem., May 26, 2000; 275(22): 16428 - 16434. [Abstract] [Full Text] [PDF]

				J. L. Mullin, O. V. Gorkun, C. G. Binnie, and S. T. Lord Recombinant Fibrinogen Studies Reveal That Thrombin Specificity Dictates Order of Fibrinopeptide Release J. Biol. Chem., August 11, 2000; 275(33): 25239 - 25246. [Abstract] [Full Text] [PDF]

				P. C. Y. Liaw, D. L. Becker, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin J. Biol. Chem., June 8, 2001; 276(24): 20959 - 20965. [Abstract] [Full Text] [PDF]